Skip to main content Skip to main navigation menu Skip to site footer
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
Search
  • Register
  • Login
  1. Home /
  2. Archives /
  3. Vol 5 No 4S (2011)

Published: 2011-09-30

Case report

  • Imatinib dose optimisation following the disease progression in a patient with metastatic GIST
    Mariangela Parodi, Monica Boitano, Luciano Canobbio
    3-6
    • PDF
  • Imatinib as adjuvant therapy for high risk GIST: a case report
    Patrizia Lista, Agostino Ponzetti
    7-12
    • PDF
  • Appropriate durations of adjuvant imatinib in patients with high-risk gastrointestinal stromal tumor (GIST) the better choice, for the year 2010
    Lucia Tozzi
    13-16
    • PDF
Information
  • For Readers
  • For Authors
  • For Librarians

METABOLIC SYNDROME. From Risk Factors to Management

Physicians can use the metabolic syndrome concept to guide focused lifestyle changes, lower blood pressure goals, and earlier intervention with aspirin, LDL-lowering drugs, and perhaps insulin-sensitizing medications. The comprehensive “ABCDE” approach presented in this book provides a memory tool for use in everyday clinical practice.

Printed version
Ebook version

Current Issue
  • Atom logo
  • RSS2 logo
  • RSS1 logo
About this Publishing System